DAHLIA BIOSCIENCES

Dahlia Biosciences is leading the development of cell-based RNA detection tools using CRISPR technology. The foundational RNA-targeting Cas9 technology was invented by Dr. Mitchell O'Connell and Dr. Sam Sternberg in the laboratory of Dr. Jennifer Doudna at UC Berkeley... Our vision is to empower scientists to study and isolate cells at high resolution via sensitive, robust, and multiplexed RNA detection in both fixed and live cells.

Primary location: San Francisco United States